Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials by Staplin, N, Roddick, AJ, Emberson, J, Reith, C, Riding, A, Wonnacott, A, Kuverji, A, Bhandari, S, Baigent, C, Haynes, R, Herrington, WG

UK Kidney Association clinical practice guideline: sodium-glucose co-transporter-2 (sglt-2) inhibition in adults with kidney disease 2023 update by Roddick, AJ, Wonnacott, A, Webb, D, Watt, A, Watson, MA, Staplin, N, Riding, A, Lioudaki, E, Kuverji, A, El Kossi, M, Holmes, P, Holloway, M, Fraser, D, Carvalho, C, Burton, JO, Bhandari, S, Herrington, WG, Frankel, AH